Dinner could be a palm-sized portion of lean protein alongside roasted vegetables, eaten slowly and stopped at comfortable fullness
Why this trial matters: First global Phase III success in a disease with no approved targeted therapy Could change management of systemic symptoms and glandular dysfunction Gene Therapy Phase III in Epidermolysis Bullosa Shows Healing Benefit A Phase III gene therapy trial for epidermolysis bullosa (EB) demonstrated significantly better wound healing, less pain, and reduced itching compared with standard care, and the therapy earned FDA approval in 2025 a major advance for this previously untreatable genetic skin disorder
There is no data about how safe or effective these treatments are or what potential complications could arise as a result, Ashton Collins, director of Save Face, told the South Florida Sun Sentinel
Melanotan 2 is scientifically related to pigmentation pathways, but it also a lot of uncertainty
This bacterial colonization not only causes digestive discomfort such as acidity, reflux, and bloating but also weakens the integrity of your stomachs protective mucosa, paving the way for inflammation and ulcers
Until then, individuals taking semaglutide should pay attention to their mood and report any concerns to their doctors